These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 1838677)
1. Preproenkephalin messenger RNA-containing neurons in striatum of patients with symptomatic and presymptomatic Huntington's disease: an in situ hybridization study. Albin RL; Qin Y; Young AB; Penney JB; Chesselet MF Ann Neurol; 1991 Oct; 30(4):542-9. PubMed ID: 1838677 [TBL] [Abstract][Full Text] [Related]
2. Reduced expression of preproenkephalin in striatal neurons from Huntington's disease patients. Richfield EK; Maguire-Zeiss KA; Cox C; Gilmore J; Voorn P Ann Neurol; 1995 Mar; 37(3):335-43. PubMed ID: 7695232 [TBL] [Abstract][Full Text] [Related]
3. Preferential loss of preproenkephalin versus preprotachykinin neurons from the striatum of Huntington's disease patients. Richfield EK; Maguire-Zeiss KA; Vonkeman HE; Voorn P Ann Neurol; 1995 Dec; 38(6):852-61. PubMed ID: 8526457 [TBL] [Abstract][Full Text] [Related]
4. Cannabinoid (CB(1)), GABA(A) and GABA(B) receptor subunit changes in the globus pallidus in Huntington's disease. Allen KL; Waldvogel HJ; Glass M; Faull RL J Chem Neuroanat; 2009 Jul; 37(4):266-81. PubMed ID: 19481011 [TBL] [Abstract][Full Text] [Related]
5. Loss of striatal histamine H2 receptors in Huntington's chorea but not in Parkinson's disease: comparison with animal models. Martínez-Mir MI; Pollard H; Moreau J; Traiffort E; Ruat M; Schwartz JC; Palacios JM Synapse; 1993 Nov; 15(3):209-20. PubMed ID: 7904088 [TBL] [Abstract][Full Text] [Related]
6. Selective vulnerability in Huntington's disease: preferential loss of cannabinoid receptors in lateral globus pallidus. Richfield EK; Herkenham M Ann Neurol; 1994 Oct; 36(4):577-84. PubMed ID: 7944290 [TBL] [Abstract][Full Text] [Related]
7. Differential changes in striatal projection neurons in R6/2 transgenic mice for Huntington's disease. Sun Z; Del Mar N; Meade C; Goldowitz D; Reiner A Neurobiol Dis; 2002 Dec; 11(3):369-85. PubMed ID: 12586547 [TBL] [Abstract][Full Text] [Related]
8. The fate of striatal dopaminergic neurons in Parkinson's disease and Huntington's chorea. Huot P; Lévesque M; Parent A Brain; 2007 Jan; 130(Pt 1):222-32. PubMed ID: 17142832 [TBL] [Abstract][Full Text] [Related]
9. Dopamine D1 and D2 receptor gene expression in the striatum in Huntington's disease. Augood SJ; Faull RL; Emson PC Ann Neurol; 1997 Aug; 42(2):215-21. PubMed ID: 9266732 [TBL] [Abstract][Full Text] [Related]
10. Preferential loss of striato-external pallidal projection neurons in presymptomatic Huntington's disease. Albin RL; Reiner A; Anderson KD; Dure LS; Handelin B; Balfour R; Whetsell WO; Penney JB; Young AB Ann Neurol; 1992 Apr; 31(4):425-30. PubMed ID: 1375014 [TBL] [Abstract][Full Text] [Related]
11. Quantitative non-radioactive in situ hybridization of preproenkephalin mRNA with digoxigenin-labeled cRNA probes. Robbins E; Baldino F; Roberts-Lewis JM; Meyer SL; Grega D; Lewis ME Anat Rec; 1991 Dec; 231(4):559-62. PubMed ID: 1793181 [TBL] [Abstract][Full Text] [Related]
12. Striatal interneurons in Huntington's disease: selective increase in the density of calretinin-immunoreactive medium-sized neurons. Cicchetti F; Parent A Mov Disord; 1996 Nov; 11(6):619-26. PubMed ID: 8914086 [TBL] [Abstract][Full Text] [Related]
13. Diminished hippocalcin expression in Huntington's disease brain does not account for increased striatal neuron vulnerability as assessed in primary neurons. Rudinskiy N; Kaneko YA; Beesen AA; Gokce O; Régulier E; Déglon N; Luthi-Carter R J Neurochem; 2009 Oct; 111(2):460-72. PubMed ID: 19686238 [TBL] [Abstract][Full Text] [Related]
14. Selective loss of striatal preprotachykinin neurons in a phenocopy of Huntington's disease. Richfield EK; Vonsattel JP; MacDonald ME; Sun Z; Deng YP; Reiner A Mov Disord; 2002 Mar; 17(2):327-32. PubMed ID: 11921119 [TBL] [Abstract][Full Text] [Related]
15. Striatal and nigral neuron subpopulations in rigid Huntington's disease: implications for the functional anatomy of chorea and rigidity-akinesia. Albin RL; Reiner A; Anderson KD; Penney JB; Young AB Ann Neurol; 1990 Apr; 27(4):357-65. PubMed ID: 1972318 [TBL] [Abstract][Full Text] [Related]
16. Neurogenesis in the striatum of the quinolinic acid lesion model of Huntington's disease. Tattersfield AS; Croon RJ; Liu YW; Kells AP; Faull RL; Connor B Neuroscience; 2004; 127(2):319-32. PubMed ID: 15262322 [TBL] [Abstract][Full Text] [Related]
17. The fate of the large striatal interneurons expressing calretinin in Huntington's disease. Massouh M; Wallman MJ; Pourcher E; Parent A Neurosci Res; 2008 Dec; 62(4):216-24. PubMed ID: 18801393 [TBL] [Abstract][Full Text] [Related]
18. Distribution of glutamate and preproenkephalin messenger RNAs following transient focal cerebral ischemia. Friedman LK; Belayev L; Alfonso OF; Ginsberg MD Neuroscience; 2000; 95(3):841-57. PubMed ID: 10670452 [TBL] [Abstract][Full Text] [Related]
19. Preproenkephalin and preprotachykinin messenger RNA expression in normal human basal ganglia and in Parkinson's disease. Nisbet AP; Foster OJ; Kingsbury A; Eve DJ; Daniel SE; Marsden CD; Lees AJ Neuroscience; 1995 May; 66(2):361-76. PubMed ID: 7477878 [TBL] [Abstract][Full Text] [Related]
20. Lipopolysaccharide induces preproenkephalin transcription in hypophysiotropic neurons of the rat paraventricular hypothalamic nucleus suggesting a neuroendocrine role for enkephalins during immune stress. Engström L; Mackerlova L; Blomqvist A Neuroscience; 2006 Oct; 142(3):781-8. PubMed ID: 16949213 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]